Home/SEC 13D/G/NGNESEC 13D/GNGNE - Neurogene Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified$NGNE$35.63▲ 76.74% YTDHealthcareAug 14, 2026 · ThinkSabio BlogSEC Filing Update: #NGNE Neurogene Inc. : $35.63 Sector: Healthcare | YTD: 🔼+ 76.74% The SEC disclosed Today (14-AUG-2026) that BALYASNY ASSET MANAGEMENT LLC has INCREASED #NGNE Shares by 13.96% 🟢 * Previous Holdings: 718.39K Shares * Current Holdings: 818.71K Shares * Increase+100.32K * Increased(%)+13.96% * Ownership: 5.18% * Estimated Investment Value: $3.56M https://www.thinksabio.com/reports/isr/NGNE Institutional ownership in #NGNE has been steadily rising over the past 3 quarters in Shares: Q3 2025: 15.30M Q4 2025: 16.51M Q1 2026: 16.97M Share this post🔗Copy Link💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G